Melinta Therapeutics Inc (MLNTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -157,192 | -58,916 | -73,932 | -78,676 | -61,649 |
| Depreciation Amortization | 16,901 | 451 | 497 | 624 | 844 |
| Accounts receivable | -5,044 | -3,140 | 43 | -228 | -724 |
| Accounts payable and accrued liabilities | 8,285 | -1,269 | -21 | -2,874 | 5,620 |
| Other Working Capital | -49,732 | -1,353 | -3,171 | 3,321 | 8,728 |
| Other Operating Activity | 15,237 | -11,371 | 6,004 | 5,279 | -1,911 |
| Operating Cash Flow | $-171,545 | $-75,598 | $-70,580 | $-72,554 | $-49,092 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,690 | -849 | -463 | -688 | -52 |
| Net Acquisitions | -166,382 | 161,410 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -2,000 | -5,500 | N/A | N/A | N/A |
| Other Investing Activity | -2,000 | -5,500 | 0 | 0 | 0 |
| Investing Cash Flow | $-170,072 | $155,061 | $-463 | $-688 | $-52 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 112,893 | 63,370 | 44,111 | 10,000 | 3,000 |
| Debt Repayment | -47,609 | -24,503 | -5,498 | N/A | N/A |
| Common Stock Issued | 239,992 | 88 | 65 | 365 | 48,886 |
| Other Financing Activity | -10,238 | -1,240 | 13,616 | 82,494 | -132 |
| Financing Cash Flow | $295,038 | $37,715 | $52,294 | $92,859 | $51,754 |
| Beginning Cash Position | 128,587 | 11,409 | 30,158 | 10,541 | 96,503 |
| End Cash Position | 82,008 | 128,587 | 11,409 | 30,158 | 99,113 |
| Net Cash Flow | $-46,579 | $117,178 | $-18,749 | $19,617 | $2,610 |
| Free Cash Flow | |||||
| Operating Cash Flow | -171,545 | -75,598 | -70,580 | -72,554 | -49,092 |
| Capital Expenditure | -1,690 | -849 | -463 | -688 | -52 |
| Free Cash Flow | -173,235 | -76,447 | -71,043 | -73,242 | -49,144 |